Changes in Rimazolen Dosage in Patients With Insomnia Under Intravenous Anesthesia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-64
SponsorBeijing Tiantan Hospital
About this trial
To compare the dosage requirement of rimazolen under intravenous anesthesia between patients with insomnia and those with normal sleep pattern.
Eligibility criteria
Qualifiers
Age of 18 - 64 years;
American Society of Anesthesiologists (ASA) physical status of I - II;
Body mass index (BMI) of 15 - 30;
Patients undergoing elective thoracoscopy, laparoscopy, hysteroscopy, open abdominal surgery, open thoracic surgery, open spinal surgery, craniotomy surgery, and digestive endoscopy under general anesthesia;
Disqualifiers
Associated with any neurological disease;
Daily alcohol consumption;
Any contraindication to intravenous anesthetic drug, such as hypotension or shock;
History of allergy to any drug used in the study;
Trial design
Treatments tested in this trial
- No interventions, it is a observational study
Treatment groups
840 Participants
are divided into 2 treatment groupsSponsors and collaborators
Beijing Tiantan Hospital
Lead sponsor
Daxing Teaching Hospital, Capital Medical University
Collaborator
Hebei Medical University Third Hospital
Collaborator
Hengshui People's Hospital
Collaborator
Source ClinicalTrials.gov